Evidence map›Paper›PMID 38948797›Full record

ArticlebioRxiv : the preprint server for biology2024

The N-glycosylation defect in Lec5 and Lec9 CHO cells is caused by absence of the DHRSX gene.

Takfarinas Kentache, Charlotte R Althoff, Francesco Caligiore, Erika Souche, Céline Schulz, Julie Graff, Eline Pieters, Pamela Stanley, Joseph N Contessa, Emile Van Schaftingen and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Takfarinas KentacheMetabolic Research Group, de Duve Institute & WELRI, Université Catholique de Louvain, 1200 Brussels, Belgium.
Charlotte R AlthoffLaboratory for Molecular Diagnosis, Center for Human Genetics, KU Leuven, Leuven 3000, Belgium.
Francesco CaligioreMetabolic Research Group, de Duve Institute & WELRI, Université Catholique de Louvain, 1200 Brussels, Belgium.
Erika SoucheLaboratory for Cytogenetics and Genome Research, Department of Human Genetics, KU Leuven, B-3000 Leuven, Belgium.
Céline SchulzUniv. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F- 59000 Lille, France.
Julie GraffMetabolic Research Group, de Duve Institute & WELRI, Université Catholique de Louvain, 1200 Brussels, Belgium.
Eline PietersLaboratory for Molecular Diagnosis, Center for Human Genetics, KU Leuven, Leuven 3000, Belgium.
Pamela StanleyDepartment of Cell Biology, Albert Einstein College of Medicine, New York, NY, USA.
Joseph N ContessaDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06511, USA.
Emile Van SchaftingenMetabolic Research Group, de Duve Institute & WELRI, Université Catholique de Louvain, 1200 Brussels, Belgium.
Gert MatthijsLaboratory for Molecular Diagnosis, Center for Human Genetics, KU Leuven, Leuven 3000, Belgium.
François FoulquierUniv. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F- 59000 Lille, France.
Guido T BommerMetabolic Research Group, de Duve Institute & WELRI, Université Catholique de Louvain, 1200 Brussels, Belgium.
Matthew P WilsonLaboratory for Molecular Diagnosis, Center for Human Genetics, KU Leuven, Leuven 3000, Belgium.ORCID 0000-0003-2252-8730

Funding

Lectin Resistant Tumor Cells And Functional GlycomicsR01CA036434 · NCI · YESHIVA UNIVERSITY · PI STANLEY, PAMELA M · 1985 to 2011
$4.9M
Lectin Resistant Tumor Cells and Functional GlycomicsR01GM105399 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STANLEY, PAMELA M · 2013 to 2022
$3.6M
NCI NIH HHS R01 CA036434NIGMS NIH HHS R01 GM105399
6 · The paper itself

Abstract

Glycosylation-deficient Chinese hamster ovary (CHO) cell lines have been instrumental in the discovery of N-glycosylation machinery. Yet, the molecular causes of the glycosylation defects in the Lec5 and Lec9 mutants have been elusive, even though for both cell lines a defect in dolichol formation from polyprenol was previously established. We recently found that dolichol synthesis from polyprenol occurs in three steps consisting of the conversion of polyprenol to polyprenal by DHRSX, the reduction of polyprenal to dolichal by SRD5A3 and the reduction of dolichal to dolichol, again by DHRSX. This led us to investigate defective dolichol synthesis in Lec5 and Lec9 cells. Both cell lines showed increased levels of polyprenol and its derivatives, concomitant with decreased levels of dolichol and derivatives, but no change in polyprenal levels, suggesting DHRSX deficiency. Accordingly, N-glycan synthesis and changes in polyisoprenoid levels were corrected by complementation with human DHRSX but not with SRD5A3. Furthermore, the typical polyprenol dehydrogenase and dolichal reductase activities of DHRSX were absent in membrane preparations derived from Lec5 and Lec9 cells, while the reduction of polyprenal to dolichal, catalyzed by SRD5A3, was unaffected. Long-read whole genome sequencing of Lec5 and Lec9 cells did not reveal mutations in the ORF of

Indexed as

CHO glycosylation mutantsdolicholglycobiologyglycoconjugateglycoprotein biosynthesisGlycosylationisoprenoidlipid synthesisN-linked glycosylationpolyprenalpolyprenol

Identifiers

PMID38948797
PMCPMC11212957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.